Skip to content

Clinical trials

Lung Neoplasms trials in Portugal

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Lung Neoplasms Country / region: Portugal Clear all

35 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20062
20072
20091
20131
20141
20181
20193
20201
20225
20233
20244
20256
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed16
Recruiting8
Active, not recruiting6
Not yet recruiting3
Terminated1
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AstraZeneca4
Hoffmann-La Roche3
Novartis Pharmaceuticals3
Amgen2
Genzyme, a Sanofi Company2
Gustave Roussy, Cancer Campus, Grand Paris2
Instituto Politécnico de Leiria2
Universidade Nova de Lisboa2
Actuate Therapeutics Inc.1
Aveiro University1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Lung Neoplasms35
Carcinoma, Non-Small-Cell Lung16
Neoplasms6
Adenocarcinoma of Lung3
Carcinoma3
Colorectal Neoplasms3
Lung Diseases3
Breast Neoplasms2
Carcinoma, Bronchogenic2
Neoplasm Metastasis2

Trials

Showing 26 to 35 of 35. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.